Ovid Therapeutics Inc. (OVID) Reports In-Line Q1 EPS

Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q1 EPS of ($0.12), in-line with the analyst estimate of ($0.12).

For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• Goldman Sachs Starts Intel (INTC) at Neutral
• Terreno Realty Corp (TRNO) Reiterated at Market Outperform by Citizens